Cencora management check
COR · Health Care · Health Care Distributors · CEO Robert P. Mauch
Filings as of
Closest peers in Health Care Distributors
- 46CAHCardinal Health81
- 144MCKMcKesson72
- 261MRKMerck & Co.64
- 268CORCencora63
- 277PFEPfizer63
- 448HSICHenry Schein46
The seven checks
- GoodBeat its chosen peers
Have owners done well?
What $100 became since fiscal 2021
100100thDetail
$100 invested at the start of fiscal 2021 grew to $342, against $144 for the peer group the company picked itself.
- WatchPay only loosely tracked returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
6019thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.21 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Watch1.2% of net income
What does the CEO cost owners?
$18.3m pay · $1.6bn net income, FY2025
4545thDetail
$18.3m of reported pay in fiscal 2025, against $1.6bn of net income.
- WatchCEO stake ≈ 2.0 years of pay
Do they own the stock?
103,375 shares ≈ $36.1m
6 mo: ▲ $2.3m bought · ▼ $5.0m sold
5056thDetail
The CEO holds 103,375 shares, directly or through trusts (unvested awards not counted): about 2.0 years of pay. Both: 2 buyers ($2.3m) and 3 sellers ($5.0m) in six months. 3 of 5 sales ran on pre-arranged 10b5-1 plans.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −2.3% a year; flagged above +2%
Stock pay 0.0% of revenue
7971stDetail
Diluted shares changed -2.3% a year over the last three fiscal years. Stock-based pay was 0.0% of revenue in the latest year.
- Flag2 CEOs in the pay table
Is leadership stable?
15 filings under 8-K 5.02 in 3 years
CEOs: Steven H. Collis, Robert P. Mauch
107thDetail
CEOs in the pay table: Steven H. Collis, Robert P. Mauch. 15 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed January 22, 2026.
Pay tied most to Adjusted EPS
Other key measuresAdjusted Operating Income*Adjusted EPS*Adjusted Free Cash Flow*Adjusted ROIC*
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Robert P. Mauch | $18.3m | $33.9m | $6.1m | $342 | $144 | $1.6bn |
| 2024 | Steven H. Collis | $18.5m | $61.4m | $7.8m | $244 | $156 | $1.5bn |
| 2023 | Steven H. Collis | $17.5m | $33.8m | $5.1m | $193 | $128 | $1.7bn |
| 2022 | Steven H. Collis | $16.7m | $26.1m | $4.4m | $144 | $118 | $1.7bn |
| 2021 | Steven H. Collis | $14.9m | $39.8m | $4.6m | $125 | $123 | $1.5bn |
Insiders and the CEO's stakeMixed
- President & CEO
- Robert P. Mauch
- Shares held
- 103,375
- At that filing's price
- ≈ $36.1m
- Latest Form 4
- Nov 12, 2026
Both: 2 buyers ($2.3m) and 3 sellers ($5.0m) in six months. 3 of 5 sales ran on pre-arranged 10b5-1 plans.
Open-market trades by officers and directors since May 21, 2026.
- BoughtDermot Mark DurcanDirector$2.2mJun 18, 2026
- BoughtLauren M TylerDirector$149kJun 22, 2026
- SoldElizabeth S CampbellExecutive Vice President$3.7mAug 24, 2026
- SoldLazarus KrikorianSVP & Chief Accounting Officer · 10b5-1 plan$946kNov 2, 2026
Leadership and governance on file
All 22 filings
- Sep 25, 2026Leadership change8-K 5.02
- Aug 14, 2026Leadership change8-K 5.02
- Jun 15, 2026Leadership change8-K 5.02
- May 29, 2026Leadership change8-K 5.02
- Mar 17, 2026Leadership change8-K 5.02
- Jan 22, 2026Leadership change8-K 5.02
- Aug 27, 2025Leadership change8-K 5.02
- May 28, 2025Leadership change8-K 5.02
- Jan 22, 2025Leadership change8-K 5.02
- Aug 16, 2024Leadership change8-K 5.02
- Aug 15, 2024Leadership change8-K 5.02
- May 3, 2024Leadership change8-K 5.02
- Mar 15, 2024Leadership change8-K/A 5.02
- Mar 12, 2024Leadership change8-K 5.02
- Jan 16, 2024Leadership change8-K 5.02
- Aug 15, 2023Leadership change8-K 5.02
- Jan 26, 2023Leadership change8-K 5.02
- Nov 16, 2022Leadership change8-K/A 5.02
- Nov 16, 2022Leadership change8-K 5.02
- Nov 3, 2022Leadership change8-K 5.02
- Sep 27, 2022Leadership change8-K 5.02
- Apr 1, 2022Leadership change8-K 5.02
Latest shareholder vote results: Mar 6, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $5.7bn returned to owners in buybacks and dividends, 71% of net income, and $613.6m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $214.0bn | $238.6bn | $262.2bn | $294.0bn | $321.3bn |
| Net income | $1.5bn | $1.7bn | $1.7bn | $1.5bn | $1.6bn |
| Stock-based pay | $99.6m | $93.4m | $124.6m | $148.0m | $148.0m |
| Buybacks | $82.2m | $483.7m | $1.2bn | $1.5bn | $435.5m |
| Dividends | $366.6m | $391.7m | $398.8m | $416.2m | $437.1m |
| Diluted shares | 208m | 211m | 205m | 200m | 195m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.